enGene Therapeutics Inc. Warrants (ENGNW) at a glance

enGene Therapeutics Inc. Warrants (ENGNW) is a Healthcare company. It trades at $0.21, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (12/100). It is a relatively defensive holding with below-market volatility.

Price
$0.21
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
-0.29
52-week range
$0.21 to $4.20
Vestovix Score49/ 100How this works
Value
58
Growth
50
Income
40
Safety
66
Momentum
12